Related Experiment Video
Updated: Jun 4, 2026

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
Distribution of interleukin-1 receptor complex at the synaptic membrane driven by interleukin-1β and NMDA stimulation
Fabrizio Gardoni1, Mariaserena Boraso, Elisa Zianni
1Department of Pharmacological Sciences, University of Milan, Via Balzaretti 9, 20133 Milan, Italy.
Insights
Interleukin-1β (IL-1β) interacts with NMDA receptors in neurons. This study reveals a dynamic link between IL-1β signaling and NMDA receptors, impacting neuronal function and injury.
Area of Science:
- Neuroscience
- Neuroinflammation
- Molecular Biology
Background:
- Interleukin-1β (IL-1β) is a pro-inflammatory cytokine implicated in neuronal injury.
- The IL-1β signaling pathway, involving IL-1RI, MyD88, and IL-1RAcP, is well-characterized in the immune system but less understood in neurons.
- Scattered information exists on the molecular composition and distribution of IL-1β pathway components in neuronal cells.
Purpose of the Study:
- To investigate the distribution and molecular interactions of IL-1β signaling components within hippocampal neurons.
- To determine the relationship between IL-1β receptor type I (IL-1RI) and NMDA receptors in neuronal cells.
- To elucidate the functional consequences of IL-1β and NMDA receptor interactions on synaptic function.
Main Methods:
- Immunohistochemistry and subcellular fractionation to analyze protein distribution in hippocampal neurons.
- Co-localization studies to assess the interaction between IL-1RI and NMDA receptor subunits.
- Biochemical assays to evaluate changes in receptor expression and localization upon stimulation.
Main Results:
- IL-1RI, MyD88, and IL-1RAcP show differential distribution in the hippocampus and primary hippocampal neurons.
- IL-1RI is specifically enriched at synaptic sites and co-localizes with the GluN2B subunit of NMDA receptors.
- NMDA treatment enhances IL-1RI interaction with NMDA receptors and its synaptic membrane expression.
- IL-1β stimulation increases IL-1RI levels at synaptic sites without altering total plasma membrane levels.
Conclusions:
- A dynamic and functional interaction exists between the NMDA receptor and IL-1RI systems in neurons.
- This interaction provides a molecular basis for IL-1β's role as a neuromodulator in physiological and pathological conditions involving NMDA receptor activation.
- Findings highlight IL-1β as a potential therapeutic target for neurodegenerative diseases linked to NMDA receptor function.
Abstract:
Interleukin-1β (IL-1β) is a pro-inflammatory cytokine that contributes to neuronal injury in various degenerative diseases, and is therefore a potential therapeutic target. It exerts its biological effect by activating the interleukin-1 receptor type I (IL-1RI) and recruiting a signalling core complex consisting of the myeloid differentiation primary response protein 88 (MyD88) and the IL-1R accessory protein (IL-1RAcP). This pathway has been clearly described in the peripheral immune system, but only scattered information is available concerning the molecular composition and distribution of its members in neuronal cells. The findings of this study show that IL-1RI and its accessory proteins MyD88 and IL-1RAcP are differently distributed in the hippocampus and in the subcellular compartments of primary hippocampal neurons. In particular, only IL-1RI is enriched at synaptic sites, where it co-localises with, and binds to the GluN2B subunit of NMDA receptors. Furthermore, treatment with NMDA increases IL-1RI interaction with NMDA receptors, as well as the surface expression and localization of IL-1RI at synaptic membranes. IL-1β also increases IL-1RI levels at synaptic sites, without affecting the total amount of the receptor in the plasma membrane. Our results reveal for the first time the existence of a dynamic and functional interaction between NMDA receptor and IL-1RI systems that could provide a molecular basis for IL-1β as a neuromodulator in physiological and pathological events relying on NMDA receptor activation.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
IP3/DAG Signaling Pathway
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...

